Department of Adult Critical Care - Guy's and St Thomas' NHS Foundation Trust, St Thomas' Hospital, 1st Floor East Wing - Lambeth Palace Road, London, UK.
Crit Care. 2010;14(2):124. doi: 10.1186/cc8845. Epub 2010 Mar 5.
The accuracy of the arterial pressure-based cardiac output FloTrac-Vigileo system remains unacceptably low during haemodynamic instability. Data show that the measurement of cardiac output (CO) is strongly influenced by changes in factors that affect arterial blood pressure (ABP) - for example, vascular tone and compliance and the arterial site - independently of true changes in CO. Although in theory the autocalibration algorithm of FloTrac-Vigileo should adjust for those changes, the model undercompensates (or overcompensates) for prominent increases (or decreases) in vascular tone and compliance, making the system largely dependent on changes in ABP. These limitations make FloTrac-Vigileo accurate in stable haemodynamic conditions only, and until more robust algorithms and further validation studies become available, we should be aware that during haemodynamic instability or in extreme conditions of vasodilation or vasoconstriction, the measured CO may diverge from an independent bolus indicator dilution measurement, particularly if a peripheral artery is used. In these conditions, we advocate the use of transpulmonary indicator dilution via a femoral artery.
基于动脉压的心输出量 FloTrac-Vigileo 系统在血流动力学不稳定期间的准确性仍低得令人无法接受。有数据表明,心输出量(CO)的测量会受到多种因素的强烈影响,这些因素会影响动脉血压(ABP),例如血管张力和顺应性以及动脉部位,而与 CO 的真实变化无关。尽管理论上 FloTrac-Vigileo 的自动校准算法应该对此类变化进行调整,但该模型补偿不足(或过度补偿)血管张力和顺应性的明显增加(或减少),从而使该系统在很大程度上依赖于 ABP 的变化。这些局限性使得 FloTrac-Vigileo 仅在血流动力学稳定的情况下准确,在更强大的算法和进一步的验证研究出现之前,我们应该意识到,在心输出量不稳定或血管扩张或收缩的极端情况下,测量的 CO 可能与独立的指示剂稀释测量结果存在差异,特别是如果使用外周动脉时。在这些情况下,我们提倡通过股动脉进行经肺指示剂稀释。